Results
1 -
10 of
280
(Click
here to explore results)
- Anti-aging Drugs: From Basic Research to Clinical Practice, CHAPTER 14 Extending Lifespan by Inhibiting the Mechanistic Target of Rapamycin (mTOR). Dudley W. Lamming
, 2017
, Pages 352-375
- Anti-aging Drugs: From Basic Research to Clinical Practice, CHAPTER 15 mTOR, Aging and Cancer: Prospects for Pharmacological Interventions. Z. D. Sharp
, 2017
, Pages 376-392
- Macrocycles in Drug Discovery, CHAPTER 1 Bioactive Macrocycles from Nature. David J. Newman, Gordon M. Cragg
, 2015
, Pages 1-36
- Accounts in Drug Discovery: Case Studies in Medicinal Chemistry, Chapter 14 Uncoupling Neuroprotection from Immunosuppression: the Discovery of ILS-920. Edmund I. Graziani
, 2011
, Pages 316-331
- Privileged Scaffolds in Medicinal Chemistry: Design, Synthesis, Evaluation, Chapter 13 Natural Product Scaffolds of Value in Medicinal Chemistry. David J. Newman, Gordon M. Cragg
, 2016
, Pages 348-378
- Anti-aging Drugs: From Basic Research to Clinical Practice, CHAPTER 10 Mimetics of Caloric Restriction. Oleh Lushchak, Dmytro Gospodaryov
, 2017
, Pages 229-271
- Orphan Drugs and Rare Diseases, Chapter 12 Unleashing the Power of Semi-Synthesis: The Discovery of Torisel®. Jerauld S. Skotnicki, Magid A. Abou-Gharbia
, 2014
, Pages 347-366
- Kinase Drug Discovery, Chapter 6 Non-Protein Kinases as Therapeutic Targets. Jeroen C. Verheijen, David J. Richard, Arie Zask
, 2012
, Pages 161-217
- Drug Discovery from Natural Products, Chapter 5 Progress in Enhancing the Neurotrophic Effects of Natural FKBP Ligands. Guy T. Carter*
, 2012
, Pages 79-95
- Inhibitors of Protein–Protein Interactions: Small Molecules, Peptides and Macrocycles, Chapter 5 Macrocycles as Inhibitors of Protein–Protein Interactions. Pierre-Luc Boudreault, Christian Comeau, Eric Marsault
, 2021
, Pages 160-217